Drugs that target the abnormal ROS1 protein include: Crizotinib (Xalkori) Ceritinib (Zykadia) Lorlatinib (Lorbrena)
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Targeted Drug ROS1 Inhibitors for NSCLC industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Crizotinib
Lorlatinib
Entrectinib
Other
Market Segment by Product Application
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
Finally, the report provides detailed profile and data information analysis of leading company.
Roche
Pfizer
Beacon Pharma Limited
Drug International Limted
Incepta Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Targeted Drug ROS1 Inhibitors for NSCLC consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Targeted Drug ROS1 Inhibitors for NSCLC market by identifying its various subsegments.
3.Focuses on the key global Targeted Drug ROS1 Inhibitors for NSCLC manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Targeted Drug ROS1 Inhibitors for NSCLC with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Targeted Drug ROS1 Inhibitors for NSCLC submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Targeted Drug ROS1 Inhibitors for NSCLC Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Targeted Drug ROS1 Inhibitors for NSCLC Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Targeted Drug ROS1 Inhibitors for NSCLC Segment by Type
2.1.1 Crizotinib
2.1.2 Lorlatinib
2.1.3 Entrectinib
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Squamous Cell Carcinoma of NSCLC
2.2.2 Adenocarcinoma of NSCLC
2.2.3 Large Cell Carcinoma of NSCLC
2.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Comparison by Regions (2017-2027)
2.3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2027)
2.3.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Status and Prospect (2017-2027)
2.3.3 Europe Targeted Drug ROS1 Inhibitors for NSCLC Status and Prospect (2017-2027)
2.3.4 China Targeted Drug ROS1 Inhibitors for NSCLC Status and Prospect (2017-2027)
2.3.5 Japan Targeted Drug ROS1 Inhibitors for NSCLC Status and Prospect (2017-2027)
2.3.6 Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Targeted Drug ROS1 Inhibitors for NSCLC Industry Impact
2.5.1 Targeted Drug ROS1 Inhibitors for NSCLC Business Impact Assessment - Covid-19
2.5.2 Market Trends and Targeted Drug ROS1 Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Targeted Drug ROS1 Inhibitors for NSCLC Manufacturer Market Share
3.5 Top 10 Targeted Drug ROS1 Inhibitors for NSCLC Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
3.7 Key Manufacturers Targeted Drug ROS1 Inhibitors for NSCLC Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Targeted Drug ROS1 Inhibitors for NSCLC Industry Key Manufacturers
4.1 Roche
4.1.1 Compan Detail
4.1.2 Roche Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification
4.1.3 Roche 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification
4.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Roche News
4.3 Beacon Pharma Limited
4.3.1 Compan Detail
4.3.2 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification
4.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Beacon Pharma Limited News
4.4 Drug International Limted
4.4.1 Compan Detail
4.4.2 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification
4.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Drug International Limted News
4.5 Incepta Pharmaceuticals
4.5.1 Compan Detail
4.5.2 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification
4.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Incepta Pharmaceuticals News
5 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Segment by Big Type
5.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue and Market Share by Big Type (2017-2022)
5.2 Crizotinib Sales Growth Rate and Price
5.2.1 Global Crizotinib Sales Growth Rate (2017-2022)
5.2.2 Global Crizotinib Price (2017-2022)
5.3 Lorlatinib Sales Growth Rate and Price
5.3.1 Global Lorlatinib Sales Growth Rate (2017-2022)
5.3.2 Global Lorlatinib Price (2017-2022)
5.4 Entrectinib Sales Growth Rate and Price
5.4.1 Global Entrectinib Sales Growth Rate (2017-2022)
5.4.2 Global Entrectinib Price (2017-2022)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2017-2022)
5.5.2 Global Other Price (2017-2022)
6 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Segment by Big Application
6.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Big Application (2017-2022)
6.2 Squamous Cell Carcinoma of NSCLC Sales Growth Rate (2017-2022)
6.3 Adenocarcinoma of NSCLC Sales Growth Rate (2017-2022)
6.4 Large Cell Carcinoma of NSCLC Sales Growth Rate (2017-2022)
7 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecast
7.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue, Sales and Growth Rate (2022-2027)
7.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast by Regions (2022-2027)
7.2.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.2.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.2.3 China Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.2.4 Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.2.5 Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.2.6 Other Regions Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
7.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast by Type (2022-2027)
7.3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Forecast by Type (2022-2027)
7.3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share Forecast by Type (2022-2027)
7.4 Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast by Application (2022-2027)
7.4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Forecast by Application (2022-2027)
7.4.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Targeted Drug ROS1 Inhibitors for NSCLC Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Targeted Drug ROS1 Inhibitors for NSCLC Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Targeted Drug ROS1 Inhibitors for NSCLC
Figure Market Concentration Ratio and Market Maturity Analysis of Targeted Drug ROS1 Inhibitors for NSCLC
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Big Type
Figure Global Market Share of Targeted Drug ROS1 Inhibitors for NSCLC by Big Type in 2021
Figure Crizotinib Picture (2017-2022)
Figure Lorlatinib Picture (2017-2022)
Figure Entrectinib Picture (2017-2022)
Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Big Application
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Big Application in 2021
Figure Squamous Cell Carcinoma of NSCLC Picture
Figure Adenocarcinoma of NSCLC Picture
Figure Large Cell Carcinoma of NSCLC Picture
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Comparison by Regions (M USD) (2017-2027)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (Million US$) (2017-2027)
Figure North America Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate (2017-2027)
Figure China Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Targeted Drug ROS1 Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales by Manufacturer (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Manufacturer in 2021
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Manufacturer (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Manufacturer in 2021
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Targeted Drug ROS1 Inhibitors for NSCLC Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Targeted Drug ROS1 Inhibitors for NSCLC Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
Table Key Manufacturers Targeted Drug ROS1 Inhibitors for NSCLC Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification of Roche
Table Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification of Pfizer
Table Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Recent Development
Table Beacon Pharma Limited Company Profile
Table Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification of Beacon Pharma Limited
Table Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Beacon Pharma Limited Main Business
Table Beacon Pharma Limited Recent Development
Table Drug International Limted Company Profile
Table Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification of Drug International Limted
Table Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Drug International Limted Main Business
Table Drug International Limted Recent Development
Table Drug International Limted Main Business
Table Drug International Limted Recent Development
Table Incepta Pharmaceuticals Company Profile
Table Targeted Drug ROS1 Inhibitors for NSCLC Product Introduction, Application and Specification of Incepta Pharmaceuticals
Table Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Incepta Pharmaceuticals Main Business
Table Incepta Pharmaceuticals Recent Development
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue and Growth Rate (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales by Regions (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Regions in 2021
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Regions (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Regions in 2021
Figure North America Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure Europe Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure China Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure Japan Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Figure Other Regions Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales by Big Type (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Big Type (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Big Type in 2019
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Big Type (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Big Type (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Big Type in 2019
Figure Global Crizotinib Sales Growth Rate (2017-2022)
Figure Global Crizotinib Price (2017-2022)
Figure Global Lorlatinib Sales Growth Rate (2017-2022)
Figure Global Lorlatinib Price (2017-2022)
Figure Global Entrectinib Sales Growth Rate (2017-2022)
Figure Global Entrectinib Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales by Big Application (2017-2022)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Big Application (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Market Share by Big Application in 2019
Figure Global Squamous Cell Carcinoma of NSCLC Sales Growth Rate (2017-2022)
Figure Global Adenocarcinoma of NSCLC Sales Growth Rate (2017-2022)
Figure Global Large Cell Carcinoma of NSCLC Sales Growth Rate (2017-2022)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Sales and Growth Rate (2022-2027)
Figure Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue and Growth Rate (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Forecast by Regions (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share Forecast by Regions (2022-2027)
Figure North America Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Figure Europe Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Figure China Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Figure Japan Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Figure Southeast Asia Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Figure Other Regions Sales Targeted Drug ROS1 Inhibitors for NSCLC Market Forecast (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Forecast by Type (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share Forecast by Type (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Sales Forecast by Application (2022-2027)
Table Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Targeted Drug ROS1 Inhibitors for NSCLC
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Targeted Drug ROS1 Inhibitors for NSCLC Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Targeted Drug ROS1 Inhibitors for NSCLC Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Targeted Drug ROS1 Inhibitors for NSCLC Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Targeted Drug ROS1 Inhibitors for NSCLC Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Roche
Pfizer
Beacon Pharma Limited
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)